Correction: Interleukin−6 in complications of prematurity: from biomarker to targeted therapy - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: The Role of Interleukin−6 in Prematurity Complications: Transitioning from Biomarker to Therapeutic Target

  • By

  • Shuzhe Xiao

  • Qi Zheng

  • Lingling Wang

  • Zhiqiu Wang

  • Guangliang Bi

  • Jie Yang

  • September 10, 2026

Share

Original Source(s)

Related Content